The role of the pharmacist in the selection and use of over-the-counter proton-pump inhibitors
- PMID: 26100836
- PMCID: PMC4594082
- DOI: 10.1007/s11096-015-0150-z
The role of the pharmacist in the selection and use of over-the-counter proton-pump inhibitors
Abstract
Background: Heartburn and other symptoms of gastro-oesophageal reflux occur in ~30% of survey respondents in multiple countries worldwide. Heartburn and acid regurgitation are common complaints in the pharmacy, where patients frequently seek relief through medication and advice. The growing number of proton-pump inhibitors available in the over-the-counter setting provides an efficacious choice to patients experiencing frequent heartburn. Pharmacists can assist patients in their treatment decisions whilst inquiring about alarm symptoms that should prompt a physician referral. Aim of the review Provide pharmacists with a review of current clinical research and expert guidelines on use of over-the-counter proton-pump inhibitors.
Methods: This narrative review was conducted to identify publications relevant to the following themes: overview of available treatments for frequent episodes of heartburn/acid regurgitation; treatment algorithms providing guidance on when to use over-the-counter proton-pump inhibitors; and the role of the pharmacist in the use of over-the-counter proton-pump inhibitors.
Results: Frequent symptoms of acid reflux, such as heartburn and acid regurgitation, can interfere substantially with daily life activities. Proton-pump inhibitors are the most efficacious treatment for frequent reflux symptoms and are recommended as an appropriate initial treatment in uncomplicated cases. Proton-pump inhibitors have varying pharmacokinetics and pharmacodynamics across the class; 20 mg esomeprazole has higher bioavailability and exposure than over-the-counter omeprazole, for example. However, differences in clinical efficacy for symptom relief have not been demonstrated. The safety and tolerability of proton-pump inhibitors have been well established in clinical trial and post-marketing settings, and use of a short regimen is associated with a very low likelihood of missing a more serious condition. Pharmacists can assist patients with accurate self-diagnosis by asking short, simple questions to characterize the nature, severity, and frequency of symptoms. Additionally, pharmacists can inquire about alarm symptoms that should prompt referral to a physician. Pharmacists should inform those patients for whom over-the-counter proton-pump inhibitors are appropriate on their proper use.
Conclusion: Over-the-counter proton-pump inhibitors have a valuable role in the treatment of frequent heartburn. Pharmacists have the opportunity to guide patients through selection of the best treatment option for their symptoms.
Keywords: Counselling; Esomeprazole; Gastro-oesophageal reflux; Omeprazole; Over-the-counter therapy; Pharmacists; Proton-pump inhibitors.
Similar articles
-
Partnership in optimizing management of reflux symptoms: a treatment algorithm for over-the-counter proton-pump inhibitors.Curr Med Res Opin. 2015;31(7):1309-18. doi: 10.1185/03007995.2015.1047745. Epub 2015 Jun 15. Curr Med Res Opin. 2015. PMID: 25950642 Review.
-
Guidance on the use of over-the-counter proton pump inhibitors for the treatment of GERD.Int J Clin Pharm. 2011 Jun;33(3):493-500. doi: 10.1007/s11096-011-9489-y. Epub 2011 Apr 7. Int J Clin Pharm. 2011. PMID: 21472476
-
Implications of over-the-counter proton pump inhibitors for patient counseling by pharmacists.Am J Ther. 2013 Nov-Dec;20(6):676-84. doi: 10.1097/MJT.0b013e318217a5d1. Am J Ther. 2013. PMID: 21642828 Review.
-
Management of reflux symptoms with over-the-counter proton pump inhibitors: issues and proposed guidelines.Digestion. 2009;80(4):226-34. doi: 10.1159/000235953. Epub 2009 Oct 16. Digestion. 2009. PMID: 19844107 Review.
-
[Efficacy and safety of OTC omeprazole].MMW Fortschr Med. 2012 Dec 17;154 Suppl 4:110-4. MMW Fortschr Med. 2012. PMID: 23326929 German.
Cited by
-
Attitude and knowledge of Saudi community pharmacists towards use of proton pump inhibitors.Saudi Pharm J. 2019 Feb;27(2):225-228. doi: 10.1016/j.jsps.2018.11.002. Epub 2018 Nov 7. Saudi Pharm J. 2019. PMID: 30766433 Free PMC article.
-
Proton pump inhibitor and community pharmacies: Usage profile and factors associated with long-term use.PLoS One. 2021 Jun 10;16(6):e0252785. doi: 10.1371/journal.pone.0252785. eCollection 2021. PLoS One. 2021. PMID: 34111166 Free PMC article.
-
Population-based cohort study: proton pump inhibitor use during pregnancy in Sweden and the risk of maternal and neonatal adverse events.BMC Med. 2022 Dec 20;20(1):492. doi: 10.1186/s12916-022-02673-x. BMC Med. 2022. PMID: 36539798 Free PMC article.
-
The Safety of Appropriate Use of Over-the-Counter Proton Pump Inhibitors: An Evidence-Based Review and Delphi Consensus.Drugs. 2017 Apr;77(5):547-561. doi: 10.1007/s40265-017-0712-6. Drugs. 2017. PMID: 28233274 Free PMC article. Review.
-
Community pharmacists' response to complaints of gastroesophageal reflux: A simulated patient study in the Northern United Arab Emirates.PLoS One. 2023 Jan 6;18(1):e0279922. doi: 10.1371/journal.pone.0279922. eCollection 2023. PLoS One. 2023. PMID: 36607970 Free PMC article.
References
-
- Camilleri M, Dubois D, Coulie B, Jones M, Kahrilas PJ, Rentz AM, et al. Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study. Clin Gastroenterol Hepatol. 2005;3(6):543–552. doi: 10.1016/S1542-3565(05)00153-9. - DOI - PubMed
-
- Bretagne JF, Honnorat C, Richard-Molard B, Caekaert A, Barthelemy P. Comparative study of characteristics and disease management between subjects with frequent and occasional gastro-oesophageal reflux symptoms. Aliment Pharmacol Ther. 2006;23(5):607–616. doi: 10.1111/j.1365-2036.2006.02811.x. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical